Subcutaneous amyloidoma models for screening potential anti-fibrillating agents in vivo

Here, we describe a robust protocol using mouse models to screen potential insulin-stabilizers and insulin moieties. We have generated a mouse model of amyloidoma, found in diabetic patients undergoing insulin therapy. This model can be used to screen potential insulin stabilizers and insulin moieti...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Debajyoti, Paul, Avishek, Maity, Sujay Krishna, Chatterjee, Subhrangsu, Chakrabarti, Partha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683767/
https://www.ncbi.nlm.nih.gov/pubmed/34977673
http://dx.doi.org/10.1016/j.xpro.2021.101027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683767/
https://www.ncbi.nlm.nih.gov/pubmed/34977673
http://dx.doi.org/10.1016/j.xpro.2021.101027

Ejemplares similares